StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note released on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance Shares of NASDAQ GNCA opened at $0.00 on Thursday. Genocea Biosciences has a one year low of $0.00 and a one […]